메뉴 건너뛰기




Volumn 57, Issue , 2012, Pages 74-84

Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin- 2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors

Author keywords

ALK5 inhibitor; Cancer; Cell based luciferase reporter assay; Docking; Fibrosis; Kinase assay; TGF

Indexed keywords

2 BENZYLAMINO 4(5) (6 METHYLPYRIDIN 2 YL) 5(4) (1,2,4 TRIAZOLO[1,5 A]PYRIDIN 6 YL)THIAZOLE DERIVATIVE; BROMINE; DRUG METABOLITE; IN 1130; LUCIFERASE; MITOGEN ACTIVATED PROTEIN KINASE 14; N (3 FLUOROBENZYL) 4 (6 METHYLPYRIDIN 2 YL) 5 (1,2,4 TRIAZOLO[1,5 A]PYRIDIN 6 YL)THIAZOL 2 AMINE; NITROGEN; PROTEIN SERINE THREONINE KINASE INHIBITOR; SB 505124; SB 505154; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1 KINASE INHIBITOR; UNCLASSIFIED DRUG;

EID: 84867021810     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.09.011     Document Type: Article
Times cited : (20)

References (26)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.